Poisoning
A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent.
Subtype terms (14)
More specific conditions that are subtypes of Poisoning in the MeSH hierarchy.
- Arsenic Poisoning
4 drugs (3 approved, 1 experimental)
- Bites and Stings
16 drugs (14 approved, 2 experimental)
- Carbon Tetrachloride Poisoning
- Chemical and Drug Induced Liver Injury
44 drugs (34 approved, 10 experimental)
- Fluoride Poisoning
2 drugs approved
- Foodborne Diseases
- Gas Poisoning
1 drug experimental
- Heavy Metal Poisoning
3 drugs (2 approved, 1 experimental)
- Mycotoxicosis
- Neurotoxicity Syndromes
14 drugs (12 approved, 2 experimental)
- Organophosphate Poisoning
14 drugs (10 approved, 4 experimental)
- Plant Poisoning
- Psychoses, Substance-Induced
2 drugs approved
- Water Intoxication
1 drug approved
Drugs by status
Approved for this indication (12)
Phase 4 trials (8)
Phase 3 trials (7)
Phase 2 trials (15)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (14)
- Ain Shams University
- Cairo University
- First People's Hospital of Hangzhou
- Newcastle University
- NHS Lothian
- Postgraduate Institute of Medical Education and Research
- University of Edinburgh
- University of Florida
- University of Aberdeen
- Assiut University
- Zhejiang Chinese Medical University
- Zhejiang University
- University of Sao Paulo
- Government of Scotland
Organization Involved with Phase 3 Indications (40)
- Instituto Bioclon
- Mylan
- EmeraMed
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Institut Pasteur
- Madaus Inc
- National Cancer Institute (NCI)
- University of Arizona
- Harvard University
- Sylhet M.A.G.Osmani Medical College
- Texas Tech University
- Universidad de Murcia
- University of Peradeniya
- University of South Florida
- University of Valencia
- University of Chicago
- Food and Drug Administration
- South Asian Clinical Toxicology Research Collaboration
- Complejo Asistencial de León
- Children's Hospital of Morelos
- Institute of Child & Mother Health, Dhaka, Bangladesh
- Centre Antipoison et de Pharamacovigilance du Maroc
- FES University Hospital
- Dominican Santa Cruz Hospital
- National Autonomous University of Mexico
- Vijayshree Hospital
- Cottage Hospital Mangaon, Raigad
- Natu Hospital Chiplun, Ratnagiri
- Sane Hospital Chiplun,Ratnagiri, Maharashtra,India
- Kushte Hospital Chiplun
- +10 more
Organization Involved with Phase 2 Indications (20)
- Baskent University
- Emory University
- Heba Allah Ali Abd El-Halim Mabrouk
- Liaocheng People's Hospital
- Tanta University
- University of Rome Tor Vergata
- University of Saskatchewan
- University of Alberta
- Wenzhou Medical University
- University of Calgary
- Kafrelsheikh University
- Bangladesh Medical University
- FOMAT Medical Research
- NBMI Science AB
- Ivy Institute of Stem Cells Co. Ltd
- Wagner College
- Applied Speciation and Consulting LLC
- People's Liberation Army of China
- State of Michigan
- Healthway Compounding Pharmacy
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (11)
- National Institutes of Health (NIH)
- National Center for Research Resources (NCRR)
- National Polytechnic Institute, Mexico
- Ataturk University
- Giriraj Hospital
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Johns Hopkins University
- Ohio State University
- International Center for Diarrheal Disease Research
- University of Otago
- Czech Technical University in Prague